The Precision Paradox: Why Modern Oncology Requires Treating Less – Selectively
World Cancer Day 2026 creates a rare pause in oncology – not for awareness, but for recalibration. The theme, United by Unique, lands at a moment when the science is…
How AI is Quietly Shaping Oncology – One Workflow at a Time
- Post category:Pan Cancer/Survivorship
- Reading time:4 mins read
Every oncologist today faces the same silent pressures:Infusion chairs full. Charts unfinished. Trial slots empty. Scans waiting for review. AI isn’t the future — it’s the quiet force turning those…
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial.
- Post category:Pan Cancer
- Reading time:1 min read
The ROME trial was a multicenter, randomized phase 2 study evaluating tailored treatment (TT) based on comprehensive gen...
Oncofertility Isn’t a Guidance Problem. It’s an Implementation Problem.
- Post category:Pan Cancer/Supportive Oncology/Survivorship
- Reading time:3 mins read
A patient recently confided, "When my husband was diagnosed with cancer at 32, no one spoke to us about fertility." That gap cost them a decade - and it was preventable. Nationwide, only…
Reading the Room: A Joint Perspective From a Scientist- and Patient-Partnered Working Group on the Importance of Patient-Centered Language in the Dissemination of Cancer Research.
- Post category:Pan Cancer
- Reading time:1 min read
The publication reports on a phase II clinical trial evaluating the efficacy and safety of a novel targeted therapy in p...
ASO Visual Abstract: How Robust is the Evidence for Prehabilitation in Cancer Surgery? A Systematic Review and Fragility Index Analysis.
- Post category:Pan Cancer
- Reading time:1 min read
The publication presents a study exploring outcomes in cancer treatment within a surgical oncology setting. It evaluates...